Literature DB >> 12150333

Absence of activating mutations in the hot spots of the LH receptor and Gs-alpha genes in Leydig cell tumors.

T C A Vieira, J M Cerutti, M R Dias da Silva, R Delcelo, J Abucham.   

Abstract

Leydig-cell tumors are functioning endocrine tumors that produce T autonomously leading to isosexual precocity in boys and virilization in female patients. Molecular abnormalities such as activating mutations of the luteinizing hormone receptor (LHR), a G protein-coupled receptor, and of the Gs-alpha subunit of G protein have recently been described in these tumors. Both mutations cause continuous activation of the cAMP signaling cascade, autonomous production of T and cell proliferation. We searched for activating mutations in exon 11 of the LHR gene and in exons 8 and 9 of the Gs-a gene, which contain all hot spots for those mutations, in 4 Leydig cell tumors obtained from 4 patients (one boy with LH-independent precocious puberty and 3 women with virilization). DNA was extracted from paraffin-embedded neoplastic and non-neoplastic tissues and from peripheral lymphocytes. Hot spot regions of exons 11 of LHR and exons 8 and 9 of Gs-alpha genes were amplified by PCR and the purified PCR products were directly sequenced. No LHR or Gs-alpha gene mutations were found in the 4 tumors studied. Considering the previously reported mutations found in Leydig cell tumors, the absence of activating mutations in the hot spot regions for activating mutations in these tumors indicate molecular heterogeneity among Leydig cell tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12150333     DOI: 10.1007/bf03345082

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  39 in total

1.  A mutation in the first transmembrane domain of the lutropin receptor causes male precocious puberty.

Authors:  J Gromoll; C J Partsch; M Simoni; V Nordhoff; W G Sippell; E Nieschlag; B B Saxena
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

2.  Severe testotoxicosis phenotype associated with Asp578-->Tyr mutation of the lutrophin/choriogonadotrophin receptor gene.

Authors:  J Müller; B Gondos; S Kosugi; T Mori; A Shenker
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

3.  Deletion of the adrenocorticotropin receptor gene in human adrenocortical tumors: implications for tumorigenesis.

Authors:  M Reincke; P Mora; F Beuschlein; W Arlt; G P Chrousos; B Allolio
Journal:  J Clin Endocrinol Metab       Date:  1997-09       Impact factor: 5.958

4.  No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors.

Authors:  P J Fuller; K Verity; Y Shen; P Mamers; T Jobling; H G Burger
Journal:  J Clin Endocrinol Metab       Date:  1998-01       Impact factor: 5.958

5.  Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors.

Authors:  M C Fragoso; A C Latronico; F M Carvalho; M C Zerbini; J A Marcondes; L M Araujo; V S Lando; E T Frazzatto; B B Mendonca; S M Villares
Journal:  J Clin Endocrinol Metab       Date:  1998-06       Impact factor: 5.958

6.  Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis.

Authors:  K Yoshimoto; H Iwahana; A Fukuda; T Sano; M Itakura
Journal:  Cancer       Date:  1993-08-15       Impact factor: 6.860

7.  A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty.

Authors:  K Yano; M Saji; A Hidaka; N Moriya; A Okuno; L D Kohn; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  1995-04       Impact factor: 5.958

Review 8.  G protein abnormalities in pituitary adenomas.

Authors:  A Spada; A Lania; E Ballarè
Journal:  Mol Cell Endocrinol       Date:  1998-07-25       Impact factor: 4.102

9.  Activating point mutations of the gsp oncogene in human thyroid adenomas.

Authors:  C O'Sullivan; C M Barton; S L Staddon; C L Brown; N R Lemoine
Journal:  Mol Carcinog       Date:  1991       Impact factor: 4.784

10.  A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases.

Authors:  K Yano; A Hidaka; M Saji; M H Polymeropoulos; A Okuno; L D Kohn; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

View more
  1 in total

Review 1.  Mutations in human gonadotropin and gonadotropin-receptor genes.

Authors:  I T Huhtaniemi; A P N Themmen
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.